Vathany Kulasingam, PhD

Dr. Kulasingam's laboratory is focusing on using high-throughput “omics” technologies to understand disease pathogenesis, with a particular emphasis on cancer and rheumatic diseases and its application to clinical practice.

 

Clin Biochem. 2020 Feb 12;:
Mohammed-Ali Z, Brinc D, Kulasingam V, Selvaratnam R
Anal Bioanal Chem. 2020 Jan 06;:
Rickert DA, Gómez-Ríos GA, Nazdrajić E, Tascon M, Kulasingam V, Pawliszyn JB
J Clin Pathol. 2019 Nov 05;:
Fung AWS, Sugumar V, Ren AH, Kulasingam V
J Appl Lab Med. 2019 Oct 29;:
Taher J, Chen C, Kulasingam V
J Appl Lab Med. 2019 09;4(2):270-273
Parker ML, Stefan C, Reich HN, Kulasingam V
F1000Res. 2018;7:189
Leung F, Bernardini MQ, Liang K, Batruch I, Rouzbahman M, Diamandis EP, Kulasingam V
NPJ Precis Oncol. 2017;1(1):17
Kulasingam V, Prassas I, Diamandis EP
F1000Res. 2017;6:1832
Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V
Am J Physiol Renal Physiol. 2017 Aug 01;313(2):F184-F191
Rajasekeran H, Lytvyn Y, Bozovic A, Lovshin JA, Diamandis E, Cattran D, Husain M, Perkins BA, Advani A, Reich HN, Kulasingam V, Cherney DZI

Pages


Deputy Head, Clinical Biochemistry, University Health Network
Associate Professor, Laboratory Medicine & Pathobiology, University of Toronto